About Denise Bevers
Denise Bevers is a co-founder, president & CEO, board member at Vetmab Biosciences.
Form D filings also name Denise Bevers as a director at Hilltop Biosciences.
Denise Bevers reports to the SEC as a director or officer of 1 public company: Kindred Biosciences (KIN).
Denise Bevers first appears on SEC filings in 2013.
Experience
This experience comes from Denise Bevers's profile and from SEC filings. For roles taken from filings, the years are when the filings name Denise Bevers in the role, so the role may have started earlier or lasted longer.
Vetmab Biosciences, Inc. Current
Co-founder, President & CEO, Board Member
Founder & CEO (2022 – Present)
2022 – Present · San Diego, CA
Develops antibody treatments for veterinarians caring for dogs and cats.
CO
Connect Current
Board Member/Vice Chair
2021 – Present
LP
La Jolla Playhouse Current
Board Chair
2019 – Present
DT
DTxPharma
Chief Operating Officer
2020 – 2022
KI
Kindred Biosciences, Inc.
President and COO, director
2013 – 2021 · Public company (KIN)
KI
KindredBio
Board Member
2012 – 2021
SI
SD Scientific, Inc.
Founding Partner
2005 – 2012
EI
Elan Pharmaceuticals, Inc.
Senior Director, Medical Development and Communications
2001 – 2005
SI
SkyePharma, Inc
Project Director
2000 – 2001
QI
Quintiles, Inc.
Senior Clinical Research Associate
1997 – 2000
SF
Scripps Clinic and Research Foundation
Division Lead / Clinical Research Coordinator
1989 – 1995
Key Colleagues at Startups
The people Denise Bevers works with at each company, as listed on that company's latest Form D.
Vetmab Biosciences, Inc. · Form D, Sep 29, 2026
Richard Chin
Co-founder, Chair of the Board
Hangjun Zhan
Director
NA
Neeraj Agrawal
Director
CM
Chrysa Mineo
Director
Hilltop Biosciences Inc. · Form D/A, Mar 31, 2025
MW
Mark Williams
Executive officer and director
JM
Jessica McLear
Director
AW
Alan Watson
Director
AD
Amanda Drobnis
Chief Executive Officer and President, director